beta-(5-hydroxy-2-pyridyl)alanine has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benoit, RM; Eiseman, J; Jacobs, SC; Kyprianou, N | 1 |
| Makabe, O; Nagahara, H; Nishimura, S; Shindo-Okada, N | 1 |
2 other study(ies) available for beta-(5-hydroxy-2-pyridyl)alanine and Adenocarcinoma
| Article | Year |
|---|---|
Reversion of human prostate tumorigenic growth by azatyrosine.
Topics: Adenocarcinoma; Alanine; Animals; Antibiotics, Antineoplastic; Cell Division; Cell Transformation, Neoplastic; Clone Cells; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, SCID; Oncogenes; Point Mutation; Prostatic Neoplasms; Protein-Lysine 6-Oxidase; Proto-Oncogene Mas; Proto-Oncogene Proteins p21(ras); RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Up-Regulation | 1995 |
Permanent conversion of NIH3T3 cells transformed by activated c-Ha-ras, c-Ki-ras, N-ras, or c-raf, and of human pancreatic adenocarcinoma containing activated c-Ki-ras to apparently normal cells by treatment with the antibiotic azatyrosine.
Topics: Adenocarcinoma; Alanine; Animals; Antibiotics, Antineoplastic; Cell Division; Cell Line, Transformed; Cell Transformation, Neoplastic; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Oncogenes; Pancreatic Neoplasms; Tumor Cells, Cultured | 1990 |